MY137045A - Medicaments comprising steroids and a novel anticholinergic - Google Patents
Medicaments comprising steroids and a novel anticholinergicInfo
- Publication number
- MY137045A MY137045A MYPI20031320A MYPI20031320A MY137045A MY 137045 A MY137045 A MY 137045A MY PI20031320 A MYPI20031320 A MY PI20031320A MY PI20031320 A MYPI20031320 A MY PI20031320A MY 137045 A MY137045 A MY 137045A
- Authority
- MY
- Malaysia
- Prior art keywords
- steroids
- medicaments
- pharmaceutical compositions
- novel pharmaceutical
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
THE PRESENT INVENTION RELATES TO NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING STEROIDS WITH A LONG-LASTING EFFECT AND COMPRISING SALTS OF A NEW ANTICHOLINERGIC OF FORMULA 1.WHEREINX -DENOTES AN ANION WITH A SINGLE NEGATIVE CHARGE, PREFERABLY AN ANION SELECTED FROM THE GROUP CONSISTING OF CHLORIDE, BROMIDE, IODIDE, SULPHATE, PHOSPHATE, METHANESULPHONATE, NITRATE, MALEATE, ACETATE, CITRATE, FUMARATE, TARTRATE, OXALATE, SUCCINATE, BENZOATE AND P-TOLUENESULPHONATE. THE PRESENT INVENTION FURTHER RELATES TO PROCESSES FOR PREPARING THESE NOVEL PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF RESPIRATORY COMPLAINTS, IN PARTICULAR ASTHMA AND COPD.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10216429A DE10216429A1 (en) | 2002-04-12 | 2002-04-12 | Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY137045A true MY137045A (en) | 2008-12-31 |
Family
ID=28458802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20031320A MY137045A (en) | 2002-04-12 | 2003-04-10 | Medicaments comprising steroids and a novel anticholinergic |
Country Status (29)
| Country | Link |
|---|---|
| EP (2) | EP1496902B1 (en) |
| JP (1) | JP4559086B2 (en) |
| KR (1) | KR101010869B1 (en) |
| CN (1) | CN1646126A (en) |
| AR (1) | AR039275A1 (en) |
| AT (1) | ATE312607T1 (en) |
| AU (1) | AU2003216921B2 (en) |
| BR (1) | BR0309085A (en) |
| CA (1) | CA2481268C (en) |
| DE (2) | DE10216429A1 (en) |
| DK (1) | DK1496902T3 (en) |
| EA (1) | EA008386B1 (en) |
| EC (1) | ECSP045355A (en) |
| ES (1) | ES2254917T3 (en) |
| HR (1) | HRP20040943B1 (en) |
| IL (2) | IL164391A0 (en) |
| ME (1) | MEP54208A (en) |
| MX (1) | MXPA04009917A (en) |
| MY (1) | MY137045A (en) |
| NO (1) | NO20044097L (en) |
| NZ (1) | NZ536284A (en) |
| PE (1) | PE20040326A1 (en) |
| PL (1) | PL211227B1 (en) |
| RS (1) | RS50776B (en) |
| TW (1) | TWI311055B (en) |
| UA (1) | UA80125C2 (en) |
| UY (1) | UY27758A1 (en) |
| WO (1) | WO2003086399A1 (en) |
| ZA (1) | ZA200406751B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| CN100569235C (en) | 2004-02-06 | 2009-12-16 | Meda制药有限及两合公司 | Be used for the anticholinergic of asthma and COPD long-term treatment and the combination of glucocorticoid |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| ES2774391T3 (en) | 2009-05-29 | 2020-07-20 | Pearl Therapeutics Inc | Compositions, methods and systems for the respiratory administration of two or more active agents |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| BR112015022784B1 (en) | 2013-03-15 | 2023-02-14 | Pearl Therapeutics, Inc | MICRONIZED CRYSTALLINE MATERIAL CONDITIONING METHOD AND CONDITIONING SYSTEMS |
| CN115282411A (en) * | 2022-01-14 | 2022-11-04 | 温州医科大学 | Delivery system for delivering drugs into the brain using the nasal olfactory region and method of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| DK163640C (en) | 1985-07-30 | 1992-08-17 | Glaxo Group Ltd | DEVICE FOR ADMINISTRATING MEDICINES |
| SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
| DE4108393A1 (en) | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS |
| IL107120A (en) | 1992-09-29 | 1997-09-30 | Boehringer Ingelheim Int | Atomising nozzle and filter and spray generating device |
| DE4318455A1 (en) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Capsule holder |
| DE69632728T2 (en) * | 1995-04-28 | 2004-10-14 | Banyu Pharmaceutical Co., Ltd. | 1,4-DISUBSTITUTED PIPERID DERIVATIVES |
| DE19536902A1 (en) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Miniature fluid pressure generating device |
| DE19536903C2 (en) | 1995-10-04 | 1998-09-10 | Boehringer Ingelheim Int | Device for holding a fluidic component |
| DE19545226C1 (en) | 1995-12-05 | 1997-06-19 | Boehringer Ingelheim Int | Locking mechanism for a spring-operated output |
| GB0009591D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical combinations |
| DE10050994A1 (en) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
| MXPA03003751A (en) * | 2000-10-31 | 2004-10-15 | Boehringer Ingelheim Pharma | Novel medicament compositions based on anticholinergics and corticosteroids. |
-
2002
- 2002-04-12 DE DE10216429A patent/DE10216429A1/en not_active Withdrawn
-
2003
- 2003-04-09 AT AT03712137T patent/ATE312607T1/en active
- 2003-04-09 NZ NZ536284A patent/NZ536284A/en not_active IP Right Cessation
- 2003-04-09 RS YUP-899/04A patent/RS50776B/en unknown
- 2003-04-09 MX MXPA04009917A patent/MXPA04009917A/en active IP Right Grant
- 2003-04-09 AR ARP030101241A patent/AR039275A1/en active Pending
- 2003-04-09 AU AU2003216921A patent/AU2003216921B2/en not_active Expired
- 2003-04-09 JP JP2003583418A patent/JP4559086B2/en not_active Expired - Lifetime
- 2003-04-09 BR BR0309085-0A patent/BR0309085A/en not_active Expired - Fee Related
- 2003-04-09 WO PCT/EP2003/003668 patent/WO2003086399A1/en active IP Right Grant
- 2003-04-09 CA CA2481268A patent/CA2481268C/en not_active Expired - Lifetime
- 2003-04-09 DK DK03712137T patent/DK1496902T3/en active
- 2003-04-09 EP EP03712137A patent/EP1496902B1/en not_active Expired - Lifetime
- 2003-04-09 IL IL16439103A patent/IL164391A0/en unknown
- 2003-04-09 EA EA200401303A patent/EA008386B1/en not_active IP Right Cessation
- 2003-04-09 ES ES03712137T patent/ES2254917T3/en not_active Expired - Lifetime
- 2003-04-09 KR KR1020047016335A patent/KR101010869B1/en not_active IP Right Cessation
- 2003-04-09 DE DE50301934T patent/DE50301934D1/en not_active Expired - Lifetime
- 2003-04-09 CN CNA038083299A patent/CN1646126A/en active Pending
- 2003-04-09 EP EP05109887A patent/EP1621197A3/en not_active Withdrawn
- 2003-04-09 ME MEP-542/08A patent/MEP54208A/en unknown
- 2003-04-09 PL PL371561A patent/PL211227B1/en not_active IP Right Cessation
- 2003-04-10 UY UY27758A patent/UY27758A1/en not_active Application Discontinuation
- 2003-04-10 MY MYPI20031320A patent/MY137045A/en unknown
- 2003-04-10 PE PE2003000365A patent/PE20040326A1/en not_active Application Discontinuation
- 2003-04-10 TW TW092108227A patent/TWI311055B/en not_active IP Right Cessation
- 2003-09-04 UA UA20041109192A patent/UA80125C2/en unknown
-
2004
- 2004-08-25 ZA ZA200406751A patent/ZA200406751B/en unknown
- 2004-09-27 NO NO20044097A patent/NO20044097L/en not_active Application Discontinuation
- 2004-10-04 IL IL164391A patent/IL164391A/en not_active IP Right Cessation
- 2004-10-11 HR HRP20040943AA patent/HRP20040943B1/en not_active IP Right Cessation
- 2004-10-11 EC EC2004005355A patent/ECSP045355A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200516078A (en) | Aerosol formulation for inhalation comprising an anticholinergic | |
| AU775588B2 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| MY130803A (en) | New quinuclidine amide derivatives | |
| PL375233A1 (en) | Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs | |
| MY137045A (en) | Medicaments comprising steroids and a novel anticholinergic | |
| CA2471578A1 (en) | Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments | |
| HRP20110232T1 (en) | Muscarinic acetycholine receptor antagonists | |
| CA2395653A1 (en) | New inhalable powder containing tiotropium | |
| IL166814A0 (en) | Aerosol formulation for inhalation containing an anticholinergic agent | |
| UA85541C2 (en) | Quinuclidine carbamate derivatives and pharmaceutical compositions containing the same | |
| JP2016527220A5 (en) | ||
| IL163841A (en) | Process for preparing crystalline micronisate, crystalline tiotropium bromide micronisate and its use for preparing a pharmaceutical composition and such composition as inhalable powder | |
| JP2006506345A5 (en) | ||
| JP2002521468A5 (en) | ||
| TW200744606A (en) | Use of tiotropium salts in the treatment of severe persistent asthma | |
| NZ547276A (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
| HRP20110200T1 (en) | Use of tiotropium salts in the treatment of moderate persistent asthma | |
| MY140890A (en) | New tiotropium containing powder formulation for inhalation | |
| ZA200409676B (en) | Novel drug compositions based on novel anticholinergics and inhibitors of EGFR-kinase | |
| CA2479638A1 (en) | Hfa-suspension formulations of crystalline tiotropium bromide anhydrate | |
| AU2003222290A1 (en) | Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament | |
| GEP20033054B (en) | 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals | |
| TH65935A (en) | Drugs, which contain steroids And the new anticolinergic | |
| ATE341547T1 (en) | DIFURYL GLYCOLIC ACID TROPENOLESTER AS ANTICHOLINERGICS | |
| DE602004021815D1 (en) | MEDICAMENTS FOR INHALATION WITH STEROIDS AND A NEW FLUORESCARBOXIC ACID ESTER |